ArticleRSC medicinal chemistry2021

Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy.

Sang-Yong Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.